Trial · NCT03829657
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| OL Treatment Period (Week 1 to Week 16) | STARTED | OL Treatment Period: 0169 Placebo Rollover | 85 | |
| OL Treatment Period (Week 1 to Week 16) | STARTED | OL Treatment Period: 0169 Ampreloxetine Rollover | 85 | |
| OL Treatment Period (Week 1 to Week 16) | STARTED | OL Treatment Period: De Novo | 33 | |
| OL Treatment Period (Week 1 to Week 16) | STARTED | RW Treatment Period: Placebo | 0 | |
| OL Treatment Period (Week 1 to Week 16) | STARTED | RW Treatment Period: Ampreloxetine | 0 | |
| OL Treatment Period (Week 1 to Week 16) | COMPLETED | OL Treatment Period: 0169 Placebo Rollover | 52 | |
| OL Treatment Period (Week 1 to Week 16) | COMPLETED | OL Treatment Period: 0169 Ampreloxetine Rollover | 64 | |
| OL Treatment Period (Week 1 to Week 16) | COMPLETED | OL Treatment Period: De Novo | 12 | |
| OL Treatment Period (Week 1 to Week 16) | COMPLETED | RW Treatment Period: Placebo | 0 | |
| OL Treatment Period (Week 1 to Week 16) | COMPLETED | RW Treatment Period: Ampreloxetine | 0 | |
| OL Treatment Period (Week 1 to Week 16) | NOT COMPLETED | OL Treatment Period: 0169 Placebo Rollover | 33 | |
| OL Treatment Period (Week 1 to Week 16) | NOT COMPLETED | OL Treatment Period: 0169 Ampreloxetine Rollover | 21 | |
| OL Treatment Period (Week 1 to Week 16) | NOT COMPLETED | OL Treatment Period: De Novo | 21 | |
| OL Treatment Period (Week 1 to Week 16) | NOT COMPLETED | RW Treatment Period: Placebo | 0 | |
| OL Treatment Period (Week 1 to Week 16) | NOT COMPLETED | RW Treatment Period: Ampreloxetine | 0 | |
| RW Treatment Period (Week 16 to Week 24) | STARTED | OL Treatment Period: 0169 Placebo Rollover | 0 | |
| RW Treatment Period (Week 16 to Week 24) | STARTED | OL Treatment Period: 0169 Ampreloxetine Rollover | 0 | |
| RW Treatment Period (Week 16 to Week 24) | STARTED | OL Treatment Period: De Novo | 0 | |
| RW Treatment Period (Week 16 to Week 24) | STARTED | RW Treatment Period: Placebo | 64 | |
| RW Treatment Period (Week 16 to Week 24) | STARTED | RW Treatment Period: Ampreloxetine | 64 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03829657/flow